Completed NA INTERVENTIONAL 2-arm NCT01178840

Prostate Specific Antigen (PSA) and Acute Failure Modes Study of the PATH Woman's Condom and FC2 Female Condom (CONRAD-108)

A Randomized Cross-Over Study of Vaginal Semen Exposure and Clinical Failure Comparing the PATH Woman's Condom and the FC2 Female Condom

Sponsor: CONRAD

Conditions Birth Control

Interventions FC2 then WC WC then FC2

Updated 6 times since 2017 Last updated: Dec 11, 2013 Started: Jul 31, 2010 Primary completion: Jun 30, 2011 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01178840, this NA trial focuses on Birth Control and remains completed. Sponsored by CONRAD, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CONRAD
PATH
United States Agency for International Development (USAID)

Data source: CONRAD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States